Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.02 USD | +1.89% | -9.90% | +64.72% |
05-10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
05-09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- MarketScreener Editorial Features